PA
CVS icon

Procyon Advisors’s CVS Health CVS Stock Holding History

Procyon Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$932K Buy
9,011
+1,513
+20% +$135K 0.04% 282
2026
Q1 		$539K Buy
7,498
+3,165
+73% +$244K 0.03% 338
2025
Q4 		$344K Sell
4,333
-2,009
-32% -$158K 0.02% 406
2025
Q3 		$478K Sell
6,342
-497
-7% -$34.1K 0.03% 321
2025
Q2 		$472K Sell
6,839
-23,643
-78% -$1.55M 0.04% 292
2025
Q1 		$2.07M Buy
+30,482
New +$1.82M 0.12% 167
2024
Q4 		– Sell
-3,242
Closed -$202K – 557
2024
Q3 		$202K Buy
+3,242
New +$189K 0.01% 531
2024
Q2 		– Sell
-3,464
Closed -$276K – 529
2024
Q1 		$276K Sell
3,464
-225
-6% -$17.2K 0.02% 432
2023
Q4 		$291K Buy
3,689
+557
+18% +$39.6K 0.02% 421
2023
Q3 		$219K Buy
3,132
+46
+1% +$3.26K 0.02% 439
2023
Q2 		$213K Buy
3,086
+78
+3% +$5.55K 0.03% 421
2023
Q1 		$224K Sell
3,008
-171
-5% -$14.3K 0.04% 349
2022
Q4 		$296K Buy
3,179
+695
+28% +$67.1K 0.05% 295
2022
Q3 		$237K Sell
2,484
-12
-0.5% -$1.19K 0.06% 279
2022
Q2 		$231K Sell
2,496
-5,677
-69% -$554K 0.05% 283
2022
Q1 		$827K Buy
8,173
+5,416
+196% +$569K 0.17% 121
2021
Q4 		$284K Buy
2,757
+107
+4% +$9.89K 0.06% 261
2021
Q3 		$225K Sell
2,650
-466
-15% -$39K 0.06% 290
2021
Q2 		$260K Sell
3,116
-1,291
-29% -$106K 0.07% 246
2021
Q1 		$332K Sell
4,407
-469
-10% -$34.2K 0.15% 159
2020
Q4 		$333K Buy
4,876
+446
+10% +$29K 0.16% 146
2020
Q3 		$259K Buy
4,430
+141
+3% +$8.77K 0.14% 159
2020
Q2 		$279K Buy
4,289
+1,566
+58% +$98.6K 0.15% 134
2020
Q1 		$162K Buy
2,723
+428
+19% +$28.6K 0.11% 179
2019
Q4 		$170K Buy
+2,295
New +$161K 0.1% 191

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Procyon Advisors's CVS Position: Q2 2026 in Review

Procyon Advisors increased its CVS Health (CVS) stake by 20% in Q2 2026, buying an estimated $135K and bringing the position to 9,011 shares worth $932K. The position accounts for 0.04% of the portfolio, ranked #282.

Procyon Advisors first reported a position in CVS in Q4 2019 and has held it in 25 quarters since. The position peaked at $2.07M in Q1 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Procyon Advisors held 9,011 shares of CVS Health worth $932K as of Q2 2026.
  • Procyon Advisors bought 1,513 CVS Health shares in Q2 2026, an estimated $135K.
  • CVS Health made up 0.04% of Procyon Advisors's portfolio in Q2 2026, its #282 holding.
  • Procyon Advisors first reported a position in CVS Health in Q4 2019 and has held it in 25 quarters since.
  • Procyon Advisors's CVS Health position peaked at $2.07M in Q1 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.